Overview

Short-range Radiotherapy Sequential Tislelizumab Combined With Chemotherapy Versus Long Range Radiotherapy and Chemotherapy Combined With Tislelizumab Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Status:
Not yet recruiting

Trial end date:
2026-09-01

Target enrollment:

Participant gender:

Summary

To compare the efficacy of short-range radiotherapy combined with sequential immunochemotherapy and long range chemoradiotherapy combined with neoadjuvant immunotherapy for locally advanced rectal cancer

Phase:

Phase 2

Details

Lead Sponsor:

Fujian Cancer Hospital

Treatments:

Capecitabine
Oxaliplatin